日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Autocrine activity of engineered IL-33 mRNA enhances adoptive T-cell therapy for peritoneal carcinomatosis and synergizes with IL-12 mRNA.

工程化IL-33 mRNA的自分泌活性增强了过继性T细胞疗法对腹膜癌的疗效,并与IL-12 mRNA具有协同作用。

Arrizabalaga Leire, Di Trani Claudia Augusta, Gomar Celia, Moreno-Luqui Daniel, Ardaiz Nuria, Belsue Virginia, González-Gomariz José, Ruiz-Guillamon David, Risson Aline, Zheng Yufei, Huarte Eduardo, Matos Ignacio, Melero Ignacio, Berraondo Pedro, Aranda Fernando

Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS-chemokine-myeloid axis

染色体不稳定性通过cGAS-趋化因子-髓系轴塑造食管腺癌的肿瘤微环境。

Beernaert, Bruno; Jady-Clark, Rose L; Shah, Parin; Ramon-Gil, Erik; Lawson, Nora M; Brodtman, Zack D; Tagore, Somnath; Stihler, Frederik; Carter, Alfie S; Clarke, Shannique; Liu, Tong; Zhu, Winston M; Martin, Juliet E; Erdal, Erkin; Easton, Alistair; Campo, Leticia; Browne, Molly; Ash, Stephen; Raja, Rabial Q; Waddell, Nicola; Crosby, Tom; Lord, Simon R; Mann, Derek A; Melero, Ignacio; de Andrea, Carlos E; Tijhuis, Andréa E; Foijer, Floris; Hammond, Ester M; Akdemir, Kadir C; Leslie, Jack; Izar, Benjamin; Parkes, Eileen E

Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumors

一项针对晚期实体瘤患者的 cergutuzumab amunaleukin I 期研究的活性生物标志物

Melero, Ignacio; Steeghs, Neeltje; Lassen, Ulrik; Homicsko, Krisztian; Tabernero, Josep; Cañamero, Marta; Roller, Andreas; Duarte, José; Rossmann, Eva; Babitzki, Galina; Grabole, Nils; Watson, Carl; Habigt, Christin; Evers, Stefan; Dejardin, David; Teichgräber, Volker; Charo, Jehad

Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen-Positive Advanced/Metastatic Solid Tumors

Cergutuzumab Amunaleukin 与 Atezolizumab 联合治疗癌胚抗原阳性晚期/转移性实体瘤患者

Melero, Ignacio; Tabernero, Josep; Steeghs, Neeltje; Robbrecht, Debbie G J; Peters, Solange; Rizvi, Naiyer A; O'Reilly, Eileen M; Calvo, Emiliano; Eefsen, Rikke L; Leighl, Natasha; Cervantes, Andres; Hafez, Navid; Habigt, Christin; Andersson, Emilia; Dejardin, David; Rossmann, Eva; Martinez Quetglas, Iris; Babitzki, Galina; Duarte, José; Adessi, Celine; Boetsch, Christophe; Evers, Stefan; Charo, Jehad; Teichgräber, Volker; Lassen, Ulrik

Conventional type-1 DC density is associated with checkpoint inhibitor response across multiple types of cancer

传统1型树突状细胞密度与多种癌症类型的免疫检查点抑制剂反应相关。

Yi, Jiping; Wang, Yougen; Zhang, Hualing; Yang, Xiuhong; Xiong, Tianci; Xie, Huanhuan; Zhan, Lichao; Zeng, Ming; Qu, Rui; Gu, Jiaqi; Luo, Yi; Yang, Luo; Dai, Yi; Lopez-Janeiro, Alvaro; González-Gomariz, José; Issa, Fadi; Hester, Joanna; Porciuncula, Angelo; Teijeira, Alvaro; Luri-Rey, Carlos; Ruiz-Guillamon, David; Perez-Gracia, Jose Luis; Perez-Ruiz, Elisabeth; Barragan, Isabel; Martín-Algarra, Salvador; Sanmamed, Miguel F; Ortego, Ignacio; Rodriguez-Ruiz, Maria E; Alexandru, Raluca; Rodriguez, Inmaculada; Arrieta-Aranzueque, Saioa; Rimm, David; Aung, Thazin; Schalper, Kurt A; de Andrea, Carlos E; Melero, Ignacio

Correction: Grant et al. Low pH, High Stakes: A Narrative Review Exploring the Acid-Sensing GPR65 Pathway as a Novel Approach in Renal Cell Carcinoma. Cancers 2025, 17, 3883

更正:Grant 等人,《低 pH 值,高风险:探索酸敏感 GPR65 通路作为肾细胞癌新方法的叙述性综述》,Cancers 2025, 17, 3883

Grant, Michael; Cipriani, Barbara; Corbin, Alastair; Miller, David; Naylor, Alan; Hughes, Stuart; McCarthy, Tom; Ambarkhane, Sumeet; Memon, Danish; Millward, Michael; Pal, Sumanta; Melero, Ignacio

First-in-human phase 1 dose-escalation study of W0180, an anti-VISTA monoclonal antibody, with and without pembrolizumab in patients with locally advanced or metastatic solid tumours

首次人体1期剂量递增研究,评估抗VISTA单克隆抗体W0180联合或不联合帕博利珠单抗治疗局部晚期或转移性实体瘤患者的疗效。

Gomez-Roca, Carlos; Champiat, Stéphane; Danlos, Francois-Xavier; Castañón Álvarez, Eduardo; Cassier, Philippe Alexandre; Dupuy, Elena; Jegou, David; Primard, Marie; Pétain, Aurélie; Saccareau, Mathilde; Gueguen-Dorbes, Geneviève; Fabre, Claire; Marabelle, Aurélien; Melero, Ignacio

Dual ENPP1/ATM depletion blunts DNA damage repair boosting radioimmune efficacy to abrogate triple-negative breast cancer

ENPP1/ATM双重缺失会削弱DNA损伤修复,从而增强放射免疫疗法对三阴性乳腺癌的疗效。

Ruiz-Fernández de Córdoba, Borja; Valencia, Karmele; Welch, Connor; Moreno, Haritz; Martínez-Canarias, Susana; Zandueta, Carolina; Gómez, Eduardo; Calvo, Alfonso; Otegui, Nerea; Echepare, Mirari; Garzón, Ignacio; Ajona, Daniel; Lara-Astiaso, David; Guruceaga, Elisabeth; Guembe, Laura; Pío, Rubén; Melero, Ignacio; Vicent, Silve; Pastor, Fernando; Martínez-Monge, Rafael; Lecanda, Fernando

Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial

Autogene cevumeran联合或不联合atezolizumab治疗晚期实体瘤:一项I期试验

Lopez, Juanita; Powles, Thomas; Braiteh, Fadi; Siu, Lillian L; LoRusso, Patricia; Friedman, Claire F; Balmanoukian, Ani S; Gordon, Michael; Yachnin, Jeffrey; Rottey, Sylvie; Karydis, Ioannis; Fisher, George A; Schmidt, Marcus; Schuler, Martin; Sullivan, Ryan J; Burris, Howard A; Galvao, Vladimir; Henick, Brian S; Dirix, Luc; Jaeger, Dirk; Ott, Patrick A; Wong, Kit Man; Jerusalem, Guy; Schiza, Aglaia; Fong, Lawrence; Steeghs, Neeltje; Leidner, Rom S; Rittmeyer, Achim; Laurie, Scott A; Gort, Eelke; Aljumaily, Raid; Melero, Ignacio; Sabado, Rachel L; Rhee, Ina; Mancuso, Michael R; Muller, Lars; Fine, Gregg D; Yadav, Mahesh; Kim, Leesun; Leveque, Vincent J P; Robert, Alberto; Darwish, Martine; Qi, Ting; Zhu, Jiawen; Zhang, Jingbin; Twomey, Patrick; Rao, Gautham K; Low, Donald W; Petry, Chris; Lo, Amy A; Schartner, Jill M; Delamarre, Lélia; Mellman, Ira; Löwer, Martin; Müller, Felicitas; Derhovanessian, Evelyna; Cortini, Andrea; Manning, Luisa; Maurus, Daniel; Brachtendorf, Sebastian; Lörks, Verena; Omokoko, Tana; Godehardt, Eva; Becker, Dirk; Hawner, Christine; Wallrapp, Christine; Albrecht, Christian; Kröner, Christoph; Tadmor, Arbel D; Diekmann, Jan; Vormehr, Mathias; Jork, Anette; Paruzynski, Anna; Lang, Maren; Blake, Jonathon; Hennig, Oliver; Kuhn, Andreas N; Sahin, Ugur; Türeci, Özlem; Camidge, D Ross

Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours

作者更正:中和 GDF-15 可以克服实体瘤中的抗 PD-1 和抗 PD-L1 耐药性

Melero, Ignacio; de Miguel Luken, Maria; de Velasco, Guillermo; Garralda, Elena; Martín-Liberal, Juan; Joerger, Markus; Alonso, Guzman; Goebeler, Maria-Elisabeth; Schuler, Martin; König, David; Dummer, Reinhard; Reig, Maria; Rodriguez Ruiz, Maria-Esperanza; Calvo, Emiliano; Esteban-Villarrubia, Jorge; Oberoi, Arjun; Sabat, Paula; Soto-Castillo, Juan José; Koster, Kira-Lee; Saavedra, Omar; Sayehli, Cyrus; Gromke, Tanja; Läubli, Heinz; Ramelyte, Egle; Fortuny, Marta; Landa-Magdalena, Ana; Moreno, Irene; Torres-Jiménez, Javier; Hernando-Calvo, Alberto; Hess, Dagmar; Racca, Fabricio; Richly, Heike; Schmitt, Andreas M; Eggenschwiler, Corinne; Sanduzzi-Zamparelli, Marco; Vilalta-Lacarra, Anna; Trojan, Jörg; Koch, Christine; Galle, Peter R; Foerster, Friedrich; Trajanoski, Zlatko; Hackl, Hubert; Gogolla, Falk; Koll, Florestan J; Wild, Peter; Chun, Felix Kyoung Hwan; Reis, Henning; Lloyd, Peter; Machacek, Matthias; Gajewski, Thomas F; Fridman, Wolf H; Eggermont, Alexander M M; Bargou, Ralf; Schöniger, Sandra; Rüschoff, Josef; Tereshchenko, Anastasiia; Zink, Carina; da Silva, Antonio; Lichtenegger, Felix S; Akdemir, Julia; Rüdiger, Manfred; L'Huillier, Phil; Dutta, Aradhana; Haake, Markus; Auckenthaler, Alexandra; Gjorgjioska, Ana; Rössler, Bernhard; Hermann, Frank; Liebig, Mara; Reichhardt, Daniela; Schuberth-Wagner, Christine; Wischhusen, Jörg; Fettes, Petra; Auer, Marlene; Klar, Kathrin; Leo, Eugen